Overview |
bs-2419R-Cy3 |
KIR2DL1 Polyclonal Antibody, Cy3 Conjugated |
WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
Human |
Specifications |
Cy3 |
Rabbit |
KLH conjugated synthetic peptide derived from human CD158a/KIR2DL1 |
201-300/348 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
3802 |
Cell membrane |
Killer cell immunoglobulin-like receptor 2DL1; CD158A; Killer cell immunoglobulin like receptor 2DL1; MHC class I NK cell receptor; Natural killer associated transcript 1; NKAT 1; NKAT-1; NKAT1; p58 natural killer cell receptor clones CL-42/47.11; p58 NK receptor; p58.1 MHC class I specic NK receptor; CD158 antigen-like family member A; KI2L1_HUMAN; Natural killer-associated transcript 1; p58 NK receptor CL-42/47.11; p58.1 MHC class-I-specic NK receptor; CD158a. |
The KIR family consists of transmembrane glycoproteins of the Ig superfamily expressed on natural killer (NK) cells and a subset of human T cells. KIR2DL1 is a receptor on human NK cells for HLA-C alleles. It inhibits the activity of NK cells thus preventing cell lysis. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |